QC
IRMD icon

Quadrature Capital’s iRadimed IRMD Stock Holding History

Quadrature Capital’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,234
Closed -$230K – 1458
2025
Q3 		$230K Sell
3,234
-1,202
-27% -$80.1K ﹤0.01% 746
2025
Q2 		$265K Buy
+4,436
New +$243K ﹤0.01% 730

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Quadrature Capital's IRMD Position: Q4 2025 in Review

Quadrature Capital sold out of iRadimed (IRMD) in Q4 2025, closing a stake of 3,234 shares — an estimated $230K sold.

Quadrature Capital first reported a position in IRMD in Q2 2025 and held it in 2 quarters. The position peaked at $265K in Q2 2025. 217 funds tracked by Wall St. Rank hold IRMD as of Q4 2025.

  • Quadrature Capital reported no remaining iRadimed position as of Q4 2025 after selling out during the quarter.
  • Quadrature Capital sold 3,234 iRadimed shares in Q4 2025, an estimated $230K.
  • Quadrature Capital first reported a position in iRadimed in Q2 2025 and held it in 2 quarters.
  • Quadrature Capital's iRadimed position peaked at $265K in Q2 2025.
  • 217 funds tracked by Wall St. Rank held iRadimed as of Q4 2025.

Based on Quadrature Capital's 13F filing for Q4 2025, filed 17 Feb 2026.